|
⚲
|
| Keyboard |
| Howard Dittrich | |
|---|---|
| Firm | |
| Address | 161 E Michigan Ave, Suite 400 Kalamazoo, MI 49007 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Cirius Therapeutics Inc | 021-284449 | Executive Officer | 30.0 M of 40.5 M |
||
| Laguna Pharmaceuticals Inc | 021-244746 | Executive Officer | 4.5 M of 4.7 M |
||
| Chanrx Corp | 021-234194 | Executive Officer | 16.6 M of 31.9 M |
||
| Chanrx Corp | 021-219036 | Executive Officer | 1.0 M of 1.0 M |
||
| Iowa Approach Inc | 021-218811 | Director | 4.3 M of 8.5 M |
||
| Sorbent Therapeutics Inc | 021-217450 | Executive Officer | 6.5 M of 15.0 M |
||
| Sequel Pharmaceuticals Inc | 021-152498 | Executive Officer | 1.0 M of 9.0 M |
||
| Sequel Pharmaceuticals Inc | 021-147386 | Executive Officer | 1.4 M of 2.0 M |
||
| Sequel Pharmaceuticals Inc | 021-109636 | Executive Officer | 3.0 M of 8.4 M |
||